Detalhe da pesquisa
1.
From virtual to clinical: The discovery of PGN-1531, a novel antagonist of the prostanoid EP4 receptor.
Bioorg Med Chem Lett
; 24(9): 2212-21, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24703233
2.
Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes.
Bioorg Med Chem Lett
; 22(3): 1464-8, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22177783
3.
Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.
Bioorg Med Chem Lett
; 17(2): 370-5, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17095213
4.
Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.
Bioorg Med Chem Lett
; 17(2): 363-9, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17107790